{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T20:13:53Z","timestamp":1762460033220,"version":"3.37.3"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2021,9,29]],"date-time":"2021-09-29T00:00:00Z","timestamp":1632873600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,9,29]],"date-time":"2021-09-29T00:00:00Z","timestamp":1632873600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Hematol Malig Rep"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1007\/s11899-021-00647-z","type":"journal-article","created":{"date-parts":[[2021,9,29]],"date-time":"2021-09-29T13:05:54Z","timestamp":1632920754000},"page":"455-463","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Philadelphia-Negative Myeloproliferative Neoplasms Around the COVID-19 Pandemic"],"prefix":"10.1007","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2747-6327","authenticated-orcid":false,"given":"Tiziano","family":"Barbui","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valerio","family":"De Stefano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,9,29]]},"reference":[{"issue":"6","key":"647_CR1","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1111\/jth.14830","volume":"18","author":"S Cui","year":"2020","unstructured":"Cui S, Chen S, Li X, Liu S, Wang F. Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia. J Thromb Haemost. 2020;18(6):1421\u20134.","journal-title":"J Thromb Haemost"},{"issue":"10","key":"647_CR2","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1016\/S1473-3099(20)30434-5","volume":"20","author":"L Carsana","year":"2020","unstructured":"Carsana L, Sonzogni A, Nasr A, Rossi RS, Pellegrinelli A, Zerbi P, Rech R, Colombo R, Antinori S, Corbellino M, Galli M, Catena E, Tosoni A, Gianatti A, Nebuloni M. Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy: a two-centre descriptive study. Lancet Infect Dis. 2020;20(10):1135\u201340.","journal-title":"Lancet Infect Dis"},{"key":"647_CR3","doi-asserted-by":"crossref","unstructured":"Mesas AE, Cavero-Redondo I, \u00c1lvarez-Bueno C, Sarri\u00e1 Cabrera MA, Maffei de Andrade S, Sequ\u00ed-Dominguez I, Mart\u00ednez-Vizca\u00edno V. Predictors of in-hospital COVID-19 mortality: a comprehensive systematic review and meta-analysis exploring differences by age, sex and health conditions. PLoS One 2020;15(11):0241742.","DOI":"10.1371\/journal.pone.0241742"},{"issue":"2","key":"647_CR4","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1038\/s41375-020-01107-y","volume":"35","author":"T Barbui","year":"2021","unstructured":"\u2022\u2022 Barbui T, Vannucchi AM, Alvarez-Larran A, Iurlo A, Masciulli A, Carobbio A, Ghirardi A, Ferrari A, Rossi G, Elli E, Andrade-Campos MM, Kabat MG, Kiladjian JJ, Palandri F, Benevolo G, Garcia-Gutierrez V, Fox ML, Foncillas MA, Morcillo CM, Rumi E, Osorio S, Papadopoulos P, Bonifacio M, Cervantes KSQ, Serrano MS, Carreno-Tarragona G, Sobas MA, Lunghi F, Patriarca A, Elorza BN, Angona A, Mazo EM, Koschmieder S, Ruggeri M, Cuevas B, Hernandez-Boluda JC, Abadia EL, Cirici BX, Guglielmelli P, Garrote M, Cattaneo D, Daffini R, Cavalca F, Bellosillo B, Benajiba L, Curto-Garcia N, Bellini M, Betti S, De Stefano V, Harrison C, Rambaldi A. High mortality rate in COVID-19 patients with myeloproliferative neoplasms after abrupt withdrawal of ruxolitinib. Leukemia. 2021;35(2):485\u201393. A multicenter series of MPN patients with COVID-19 analyzing risk factors for mortality.","journal-title":"Leukemia"},{"issue":"2","key":"647_CR5","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1038\/s41375-020-0909-7","volume":"35","author":"AR Landtblom","year":"2021","unstructured":"\u2022\u2022 Landtblom AR, Andersson TM, Dickman PW, Smedby KE, Eloranta S, Batyrbekova N, Samuelsson J, Bj\u00f6rkholm M, Hultcrantz M. Risk of infections in patients with myeloproliferative neoplasms-a population-based cohort study of 8363 patients. Leukemia. 2021;35(2):476\u201384. A population-based study on the risk of infection in patients with MPN.","journal-title":"Leukemia"},{"issue":"25","key":"647_CR6","doi-asserted-by":"publisher","first-page":"2881","DOI":"10.1182\/blood.2020008824","volume":"136","author":"A Vijenthira","year":"2020","unstructured":"\u2022 Vijenthira A, Gong IY, Fox TA, Booth S, Cook G, Fattizzo B, Mart\u00edn-Moro F, Razanamahery J, Riches JC, Zwicker J, Patell R, Vekemans MC, Scarf\u00f2 L, Chatzikonstantinou T, Yildiz H, Lattenist R, Mantzaris I, Wood WA, Hicks LK. Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patients. Blood. 2020;136(25):2881\u201392. A systematic review and meta-analysis of the outcomes of patients with hematological malignancies affected from COVID-19.","journal-title":"Blood"},{"issue":"18","key":"647_CR7","first-page":"1775","volume":"323","author":"G Onder","year":"2020","unstructured":"Onder G, Rezza G, Brusaferro S. Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy. JAMA. 2020;323(18):1775\u20136.","journal-title":"JAMA"},{"issue":"11","key":"647_CR8","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1016\/j.arbres.2020.06.012","volume":"56","author":"M Posso","year":"2020","unstructured":"Posso M, Comas M, Rom\u00e1n M, Domingo L, Louro J, Gonz\u00e1lez C, Sala M, Angl\u00e8s A, Cirera I, Cots F, Fr\u00edas VM, Gea J, G\u00fcerri-Fern\u00e1ndez R, Masclans JR, Nogu\u00e8s X, V\u00e1zquez O, Villar-Garc\u00eda J, Horcajada JP, Pascual J, Castells X. Comorbidities and mortality in patients with COVID-19 aged 60 years and older in a university hospital in Spain. Arch Bronconeumol. 2020;56(11):756\u20138.","journal-title":"Arch Bronconeumol"},{"issue":"4","key":"647_CR9","doi-asserted-by":"publisher","first-page":"e216556","DOI":"10.1001\/jamanetworkopen.2021.6556","volume":"4","author":"L Finelli","year":"2021","unstructured":"Finelli L, Gupta V, Petigara T, Yu K, Bauer KA, Puzniak LA. Mortality among US patients hospitalized with SARS-CoV-2 infection in 2020. JAMA Netw Open. 2021;4(4):e216556.","journal-title":"JAMA Netw Open"},{"key":"647_CR10","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Passamonti F, Cattaneo C, Arcaini L, Bruna R, Cavo M, Merli F, Angelucci E, Krampera M, Cairoli R, Della Porta MG, Fracchiolla N, Ladetto M, Gambacorti Passerini C, Salvini M, Marchetti M, Lemoli R, Molteni A, Busca A, Cuneo A, Romano A, Giuliani N, Galimberti S, Corso A, Morotti A, Falini B, Billio A, Gherlinzoni F, Visani G, Tisi MC, Tafuri A, Tosi P, Lanza F, Massaia M, Turrini M, Ferrara F, Gurrieri C, Vallisa D, Martelli M, Derenzini E, Guarini A, Conconi A, Cuccaro A, Cudillo L, Russo D, Ciambelli F, Scattolin AM, Luppi M, Selleri C, Ortu La Barbera E, Ferrandina C, Di Renzo N, Olivieri A, Bocchia M, Gentile M, Marchesi F, Musto P, Federici AB, Candoni A, Venditti A, Fava C, Pinto A, Galieni P, Rigacci L, Armiento D, Pane F, Oberti M, Zappasodi P, Visco C, Franchi M, Grossi PA, Bert\u00f9 L, Corrao G, Pagano L, Corradini P; ITA-HEMA-COV Investigators. Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study. Lancet Haematol. 2020;7(10):e737\u2013e745. A multicenter series of patients with hematological malignancies affected from COVID-19.","DOI":"10.1016\/S2352-3026(20)30251-9"},{"issue":"1","key":"647_CR11","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1186\/s12885-019-5387-9","volume":"19","author":"T Rungjirajittranon","year":"2019","unstructured":"Rungjirajittranon T, Owattanapanich W, Ungprasert P, Siritanaratkul N, Ruchutrakool T. A systematic review and meta-analysis of the prevalence of thrombosis and bleeding at diagnosis of Philadelphia-negative myeloproliferative neoplasms. BMC Cancer. 2019;19(1):184.","journal-title":"BMC Cancer"},{"issue":"10","key":"647_CR12","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.1200\/JCO.2005.07.062","volume":"23","author":"R Marchioli","year":"2005","unstructured":"Marchioli R, Finazzi G, Landolfi R, Kutti J, Gisslinger H, Patrono C, Marilus R, Villegas A, Tognoni G, Barbui T. Vascular and neoplastic risk in a large cohort of patients with polycythemia vera. J Clin Oncol. 2005;23(10):2224\u201332.","journal-title":"J Clin Oncol"},{"issue":"19","key":"647_CR13","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.1182\/blood-2014-07-591610","volume":"124","author":"T Barbui","year":"2014","unstructured":"Barbui T, Carobbio A, Rumi E, Finazzi G, Gisslinger H, Rodeghiero F, Randi ML, Rambaldi A, Gisslinger B, Pieri L, Bertozzi I, Casetti I, Pardanani A, Passamonti F, Vannucchi AM, Tefferi A. In contemporary patients with polycythemia vera, rates of thrombosis and risk factors delineate a new clinical epidemiology. Blood. 2014;124(19):3021\u20133.","journal-title":"Blood"},{"issue":"1","key":"647_CR14","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1056\/NEJMoa1208500","volume":"368","author":"R Marchioli","year":"2013","unstructured":"Marchioli R, Finazzi G, Specchia G, Cacciola R, Cavazzina R, Cilloni D, De Stefano V, Elli E, Iurlo A, Latagliata R, Lunghi F, Lunghi M, Marfisi RM, Musto P, Masciulli A, Musolino C, Cascavilla N, Quarta G, Randi ML, Rapezzi D, Ruggeri M, Rumi E, Scortechini AR, Santini S, Scarano M, Siragusa S, Spadea A, Tieghi A, Angelucci E, Visani G, Vannucchi AM, Barbui T, CYTO-PV Collaborative Group. Cardiovascular events and intensity of treatment in polycythemia vera. N Engl J Med. 2013;368(1):22\u201333.","journal-title":"N Engl J Med."},{"issue":"1","key":"647_CR15","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1056\/NEJMoa043800","volume":"353","author":"CN Harrison","year":"2005","unstructured":"Harrison CN, Campbell PJ, Buck G, Wheatley K, East CL, Bareford D, Wilkins BS, van der Walt JD, Reilly JT, Grigg AP, Revell P, Woodcock BE, Green AR, United Kingdom Medical Research Council Primary Thrombocythemia 1 Study. Hydroxyurea compared with anagrelide in high-risk essential thrombocythemia. N Engl J Med. 2005;353(1):33\u201345.","journal-title":"N Engl J Med."},{"issue":"10","key":"647_CR16","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1182\/blood-2012-07-443770","volume":"121","author":"H Gisslinger","year":"2013","unstructured":"Gisslinger H, Gotic M, Holowiecki J, Penka M, Thiele J, Kvasnicka HM, Kralovics R, Petrides PE, ANAHYDRET Study Group. Anagrelide compared with hydroxyurea in WHO-classified essential thrombocythemia: the ANAHYDRET Study, a randomized controlled trial. Blood. 2013;121(10):1720\u20138.","journal-title":"Blood."},{"issue":"34","key":"647_CR17","doi-asserted-by":"publisher","first-page":"3361","DOI":"10.1200\/JCO.2018.78.8414","volume":"36","author":"AL Godfrey","year":"2018","unstructured":"Godfrey AL, Campbell PJ, MacLean C, Buck G, Cook J, Temple J, Wilkins BS, Wheatley K, Nangalia J, Grinfeld J, McMullin MF, Forsyth C, Kiladjian JJ, Green AR, Harrison CN, United Kingdom Medical Research Council Primary Thrombocythemia-1 Study; United Kingdom National Cancer Research Institute Myeloproliferative Neoplasms Subgroup; French Intergroup of Myeloproliferative Neoplasms; the Australasian Leukaemia and Lymphoma Group. Hydroxycarbamide plus aspirin versus aspirin alone in patients with essential thrombocythemia age 40 to 59 years without high-risk features. J Clin Oncol. 2018;36(34):3361\u20139.","journal-title":"J Clin Oncol."},{"issue":"4","key":"647_CR18","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1182\/blood-2009-08-238956","volume":"115","author":"T Barbui","year":"2010","unstructured":"Barbui T, Carobbio A, Cervantes F, Vannucchi AM, Guglielmelli P, Antonioli E, Alvarez-Larr\u00e1n A, Rambaldi A, Finazzi G, Barosi G. Thrombosis in primary myelofibrosis: incidence and risk factors. Blood. 2010;115(4):778\u201382.","journal-title":"Blood"},{"issue":"5","key":"647_CR19","doi-asserted-by":"publisher","first-page":"317","DOI":"10.7326\/M17-0028","volume":"168","author":"M Hultcrantz","year":"2018","unstructured":"Hultcrantz M, Bj\u00f6rkholm M, Dickman PW, Landgren O, Derolf \u00c5R, Kristinsson SY, Andersson TML. Risk for arterial and venous thrombosis in patients with myeloproliferative neoplasms: a population-based cohort study. Ann Intern Med. 2018;168(5):317\u201325.","journal-title":"Ann Intern Med"},{"issue":"12","key":"647_CR20","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.6004\/jnccn.2016.0169","volume":"14","author":"R Mesa","year":"2016","unstructured":"Mesa R, Jamieson C, Bhatia R, Deininger MW, Gerds AT, Gojo I, Gotlib J, Gundabolu K, Hobbs G, Klisovic RB, Kropf P, Mohan SR, Oh S, Padron E, Podoltsev N, Pollyea DA, Rampal R, Rein LA, Scott B, Snyder DS, Stein BL, Verstovsek S, Wadleigh M, Wang ES, Bergman MA, Gregory KM, Sundar H. Myeloproliferative neoplasms, version 2.2017, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2016;14(12):1572\u2013611.","journal-title":"J Natl Compr Canc Netw"},{"issue":"5","key":"647_CR21","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1038\/s41375-018-0077-1","volume":"32","author":"T Barbui","year":"2018","unstructured":"Barbui T, Tefferi A, Vannucchi AM, Passamonti F, Silver RT, Hoffman R, Verstovsek S, Mesa R, Kiladjian JJ, Hehlmann R, Reiter A, Cervantes F, Harrison C, Mc Mullin MF, Hasselbalch HC, Koschmieder S, Marchetti M, Bacigalupo A, Finazzi G, Kroeger N, Griesshammer M, Birgegard G, Barosi G. Philadelphia chromosome-negative classical myeloproliferative neoplasms: revised management recommendations from European LeukemiaNet. Leukemia. 2018;32(5):1057\u201369.","journal-title":"Leukemia"},{"issue":"26","key":"647_CR22","doi-asserted-by":"publisher","first-page":"5128","DOI":"10.1182\/blood-2012-07-444067","volume":"120","author":"T Barbui","year":"2012","unstructured":"Barbui T, Finazzi G, Carobbio A, Thiele J, Passamonti F, Rumi E, Ruggeri M, Rodeghiero F, Randi ML, Bertozzi I, Gisslinger H, Buxhofer-Ausch V, De Stefano V, Betti S, Rambaldi A, Vannucchi AM, Tefferi A. Development and validation of an International Prognostic Score of thrombosis in World Health Organization-essential thrombocythemia (IPSET-thrombosis). Blood. 2012;120(26):5128\u201333.","journal-title":"Blood"},{"issue":"11","key":"647_CR23","doi-asserted-by":"publisher","first-page":"e369","DOI":"10.1038\/bcj.2015.94","volume":"5","author":"T Barbui","year":"2015","unstructured":"Barbui T, Vannucchi AM, Buxhofer-Ausch V, De Stefano V, Betti S, Rambaldi A, Rumi E, Ruggeri M, Rodeghiero F, Randi ML, Bertozzi I, Gisslinger H, Finazzi G, Carobbio A, Thiele J, Passamonti F, Falcone C, Tefferi A. Practice-relevant revision of IPSET-thrombosis based on 1019 patients with WHO-defined essential thrombocythemia. Blood Cancer J. 2015;5(11):e369.","journal-title":"Blood Cancer J."},{"issue":"2","key":"647_CR24","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41408-021-00417-3","volume":"11","author":"T Barbui","year":"2021","unstructured":"\u2022\u2022 Barbui T, De Stefano V, Alvarez-Larran A, Iurlo A, Masciulli A, Carobbio A, Ghirardi A, Ferrari A, Cancelli V, Elli EM, Andrade-Campos MM, Kabat MG, Kiladjian JJ, Palandri F, Benevolo G, Garcia-Gutierrez V, Fox ML, Foncillas MA, Morcillo CM, Rumi E, Osorio S, Papadopoulos P, Bonifacio M, Cervantes KSQ, Serrano MS, Carreno-Tarragona G, Sobas MA, Lunghi F, Patriarca A, Elorza BN, Angona A, Mazo EM, Koschmieder S, Carli G, Cuevas B, Hernandez-Boluda JC, Abadia EL, Cirici BX, Guglielmelli P, Garrote M, Cattaneo D, Daffini R, Cavalca F, Bellosillo B, Benajiba L, Curto-Garcia N, Bellini M, Betti S, Harrison C, Rambaldi A, Vannucchi AM. Among classic myeloproliferative neoplasms, essential thrombocythemia is associated with the greatest risk of venous thromboembolism during COVID-19. Blood Cancer J. 2021;11(2):21. A multicenter series of MPN patients with COVID-19 analyzing risk factors for thrombosis.","journal-title":"Blood Cancer J"},{"issue":"8","key":"647_CR25","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1111\/jth.14888","volume":"18","author":"S Middeldorp","year":"2020","unstructured":"\u2022\u2022 Middeldorp S, Coppens M, van Haaps TF, Foppen M, Vlaar AP, M\u00fcller MCA, Bouman CCS, Beenen LFM, Kootte RS, Heijmans J, Smits LP, Bonta PI, van Es N. Incidence of venous thromboembolism in hospitalized patients with COVID-19. J Thromb Haemost. 2020;18(8):1995\u20132002. A single-center series of COVID-19 patients analyzing the incidence of venous thromboembolism.","journal-title":"J Thromb Haemost"},{"key":"647_CR26","doi-asserted-by":"publisher","first-page":"598846","DOI":"10.3389\/fcvm.2020.598846","volume":"7","author":"MFH Mohamed","year":"2021","unstructured":"Mohamed MFH, Al-Shokri SD, Shunnar KM, Mohamed SF, Najim MS, Ibrahim SI, Elewa H, Abdalla LO, El-Bardissy A, Elshafei MN, Abubeker IY, Danjuma M, Dousa KM, Yassin MA. Prevalence of venous thromboembolism in critically ill COVID-19 patients: systematic review and meta-analysis. Front Cardiovasc Med. 2021;7:598846.","journal-title":"Front Cardiovasc Med."},{"issue":"4","key":"647_CR27","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1182\/blood.2020006520","volume":"136","author":"H Al-Samkari","year":"2020","unstructured":"\u2022\u2022 Al-Samkari H, Karp Leaf RS, Dzik WH, Carlson JCT, Fogerty AE, Waheed A, Goodarzi K, Bendapudi PK, Bornikova L, Gupta S, Leaf DE, Kuter DJ, Rosovsky RP. COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection. Blood. 2020;136(4):489\u2013500. A multicenter series of COVID-19 patients analyzing the rates of bleeding and thrombosis.","journal-title":"Blood"},{"key":"647_CR28","doi-asserted-by":"publisher","first-page":"647917","DOI":"10.3389\/fmed.2021.647917","volume":"8","author":"J Gratz","year":"2021","unstructured":"Gratz J, Wiegele M, Maleczek M, Herkner H, Sch\u00f6chl H, Chwala E, Kn\u00f6bl P, Schaden E. Risk of clinically relevant venous thromboembolism in critically ill patients with COVID-19: a systematic review and meta-analysis. Front Med (Lausanne). 2021;8:647917.","journal-title":"Front Med (Lausanne)."},{"key":"647_CR29","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.ijid.2020.08.023","volume":"100","author":"YF Lu","year":"2020","unstructured":"Lu YF, Pan LY, Zhang WW, Cheng F, Hu SS, Zhang X, Jiang HY. A meta-analysis of the incidence of venous thromboembolic events and impact of anticoagulation on mortality in patients with COVID-19. Int J Infect Dis. 2020;100:34\u201341.","journal-title":"Int J Infect Dis"},{"issue":"6","key":"647_CR30","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1056\/NEJMc2011400","volume":"383","author":"VG Puelles","year":"2020","unstructured":"\u2022\u2022 Puelles VG, L\u00fctgehetmann M, Lindenmeyer MT, Sperhake JP, Wong MN, Allweiss L, Chilla S, Heinemann A, Wanner N, Liu S, Braun F, Lu S, Pfefferle S, Schr\u00f6der AS, Edler C, Gross O, Glatzel M, Wichmann D, Wiech T, Kluge S, Pueschel K, Aepfelbacher M, Huber TB. Multiorgan and renal tropism of SARS-CoV-2. N Engl J Med. 2020;383(6):590\u20132. SARS-CoV-2 viral load in autopsy different tissue samples obtained from patients who had died from COVID-19.","journal-title":"N Engl J Med"},{"issue":"10234","key":"647_CR31","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1016\/S0140-6736(20)30937-5","volume":"395","author":"Z Varga","year":"2020","unstructured":"\u2022\u2022 Varga Z, Flammer AJ, Steiger P, Haberecker M, Andermatt R, Zinkernagel AS, Mehra MR, Schuepbach RA, Ruschitzka F, Moch H. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020;395(10234):1417\u20138. Endothelial cell involvement of SARS-CoV-2 across vascular beds of different organs in a series of patients with COVID-19.","journal-title":"Lancet"},{"issue":"3","key":"647_CR32","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1080\/09537104.2021.1889310","volume":"32","author":"J Rayes","year":"2021","unstructured":"Rayes J, Jenne CN. Platelets: bridging thrombosis and inflammation. Platelets. 2021;32(3):293\u20134.","journal-title":"Platelets"},{"issue":"5","key":"647_CR33","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s11899-017-0400-3","volume":"12","author":"K Martin","year":"2017","unstructured":"Martin K. Risk factors for and management of MPN-associated bleeding and thrombosis. Curr Hematol Malig Rep. 2017;12(5):389\u201396.","journal-title":"Curr Hematol Malig Rep"},{"issue":"4","key":"647_CR34","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1007\/s11239-020-02231-3","volume":"50","author":"B Marchandot","year":"2020","unstructured":"Marchandot B, Trimaille A, Curtiaud A, Matsushita K, Jesel L, Morel O. Thromboprophylaxis: balancing evidence and experience during the COVID-19 pandemic. J Thromb Thrombolysis. 2020;50(4):799\u2013808.","journal-title":"J Thromb Thrombolysis"},{"key":"647_CR35","doi-asserted-by":"crossref","unstructured":"\u2022 Spyropoulos AC, Levy JH, Ageno W, et al. ; Subcommittee on Perioperative, Critical Care Thrombosis, Haemostasis of the Scientific, Standardization Committee of the International Society on Thrombosis and Haemostasis. Scientific and Standardization Committee communication: clinical guidance on the diagnosis, prevention, and treatment of venous thromboembolism in hospitalized patients with COVID-19. J Thromb Haemost. 2020;18(8):1859\u20131865. Clinical guidance for prevention and treatment of venous thromboembolism in COVID-19 patients from the ISTH.","DOI":"10.1111\/jth.14929"},{"issue":"3","key":"647_CR36","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1016\/j.chest.2020.05.559","volume":"158","author":"LK Moores","year":"2020","unstructured":"\u2022 Moores LK, Tritschler T, Brosnahan S, et al. Prevention, diagnosis, and treatment of VTE in patients with coronavirus disease 2019: CHEST Guideline and Expert Panel Report. Chest. 2020;158(3):1143\u201363. Clinical guidance for prevention and treatment of venous thromboembolism in COVID-19 patients from CHEST.","journal-title":"Chest"},{"issue":"3","key":"647_CR37","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1182\/bloodadvances.2020003763","volume":"5","author":"A Cuker","year":"2021","unstructured":"\u2022 Cuker A, Tseng EK, Nieuwlaat R, Angchaisuksiri P, Blair C, Dane K, Davila J, DeSancho MT, Diuguid D, Griffin DO, Kahn SR, Klok FA, Lee AI, Neumann I, Pai A, Pai M, Righini M, Sanfilippo KM, Siegal D, Skara M, Touri K, Akl EA, Bou Akl I, Boulos M, Brignardello-Petersen R, Charide R, Chan M, Dearness K, Darzi AJ, Kolb P, Colunga-Lozano LE, Mansour R, Morgano GP, Morsi RZ, Noori A, Piggott T, Qiu Y, Roldan Y, Sch\u00fcnemann F, Stevens A, Solo K, Ventresca M, Wiercioch W, Mustafa RA, Sch\u00fcnemann HJ. American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19. Blood Adv. 2021;5(3):872\u201388. Clinical guidance for prevention and treatment of venous thromboembolism in COVID-19 patients from the ASH.","journal-title":"Blood Adv"},{"key":"647_CR38","doi-asserted-by":"crossref","unstructured":"Kaptein FHJ, Stals MAM, Huisman MV, Klok FA. Prophylaxis and treatment of COVID-19 related venous thromboembolism. Postgrad Med. 2021:1\u20139.","DOI":"10.1080\/00325481.2021.1891788"},{"key":"647_CR39","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.thromres.2020.04.013","volume":"191","author":"FA Klok","year":"2020","unstructured":"Klok FA, Kruip MJHA, van der Meer NJM, Arbous MS, Gommers DAMPJ, Kant KM, Kaptein FHJ, van Paassen J, Stals MAM, Huisman MV, Endeman H. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res. 2020;191:145\u20137.","journal-title":"Thromb Res"},{"key":"647_CR40","doi-asserted-by":"publisher","unstructured":"Martinelli I, Ciavarella A, Abbattista M, Aliberti S, De Zan V, Folli C, Panigada M, Gori A, Artoni A, Ierardi AM, Carrafiello G, Monzani V, Grasselli G, Blasi F, Peyvandi F. Increasing dosages of low-molecular-weight heparin in hospitalized patients with Covid-19. Intern Emerg Med. 2021:1\u20137. https:\/\/doi.org\/10.1007\/s11739-020-02585-9.","DOI":"10.1007\/s11739-020-02585-9"},{"key":"647_CR41","doi-asserted-by":"publisher","unstructured":"\u2022 Parisi R, Costanzo S, Di Castelnuovo A, de Gaetano G, Donati MB, Iacoviello L. Different anticoagulant regimens, mortality, and bleeding in hospitalized patients with COVID-19: a systematic review and an updated meta-analysis. Semin Thromb Hemost. 2021. https:\/\/doi.org\/10.1055\/s-0041-1726034. A systematic review and meta-analysis of the impact of different anticoagulant regimens on mortality and bleeding in patients with COVID-19.","DOI":"10.1055\/s-0041-1726034"},{"key":"647_CR42","unstructured":"\u2022\u2022 INSPIRATION Investigators, Sadeghipour P, Talasaz AH, Rashidi F, Sharif-Kashani B, Beigmohammadi MT, Farrokhpour M, Sezavar SH, Payandemehr P, Dabbagh A, Moghadam KG, Jamalkhani S, Khalili H, Yadollahzadeh M, Riahi T, Rezaeifar P, Tahamtan O, Matin S, Abedini A, Lookzadeh S, Rahmani H, Zoghi E, Mohammadi K, Sadeghipour P, Abri H, Tabrizi S, Mousavian SM, Shahmirzaei S, Bakhshandeh H, Amin A, Rafiee F, Baghizadeh E, Mohebbi B, Parhizgar SE, Aliannejad R, Eslami V, Kashefizadeh A, Kakavand H, Hosseini SH, Shafaghi S, Ghazi SF, Najafi A, Jimenez D, Gupta A, Madhavan MV, Sethi SS, Parikh SA, Monreal M, Hadavand N, Hajighasemi A, Maleki M, Sadeghian S, Piazza G, Kirtane AJ, Van Tassell BW, Dobesh PP, Stone GW, Lip GYH, Krumholz HM, Goldhaber SZ, Bikdeli B. Effect of intermediate-dose vs standard-dose prophylactic anticoagulation on thrombotic events, extracorporeal membrane oxygenation treatment, or mortality among patients with COVID-19 admitted to the intensive care unit: the INSPIRATION randomized clinical trial. JAMA. 2021:e214152. A randomized controlled trial on the effects of intermediate-dose vs. standard-dose prophylactic anticoagulation in COVID-19 patients."},{"key":"647_CR43","unstructured":"https:\/\/www.hematology.org\/covid-19\/covid-19-and-myeloproliferative-neoplasms. Accessed 22 Apr 2021."},{"issue":"1","key":"647_CR44","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s13054-015-0846-4","volume":"19","author":"AJ Boyle","year":"2015","unstructured":"Boyle AJ, Di Gangi S, Hamid UI, Mottram LJ, McNamee L, White G, Cross LJ, McNamee JJ, O\u2019Kane CM, McAuley DF. Aspirin therapy in patients with acute respiratory distress syndrome (ARDS) is associated with reduced intensive care unit mortality: a prospective analysis. Crit Care. 2015;19(1):109.","journal-title":"Crit Care"},{"key":"647_CR45","doi-asserted-by":"publisher","unstructured":"\u2022 Kow CS, Hasan SS. Use of antiplatelet drugs and the risk of mortality in patients with COVID-19: a meta-analysis. J Thromb Thrombolysis. 2021:1\u20136. https:\/\/doi.org\/10.1007\/s11239-021-02436-0. A meta-analysis of the impact of antiplatelet drugs on mortality and bleeding in patients with COVID-19.","DOI":"10.1007\/s11239-021-02436-0"},{"issue":"4","key":"647_CR46","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1213\/ANE.0000000000005292","volume":"132","author":"JH Chow","year":"2021","unstructured":"\u2022\u2022 Chow JH, Khanna AK, Kethireddy S, Yamane D, Levine A, Jackson AM, McCurdy MT, Tabatabai A, Kumar G, Park P, Benjenk I, Menaker J, Ahmed N, Glidewell E, Presutto E, Cain S, Haridasa N, Field W, Fowler JG, Trinh D, Johnson KN, Kaur A, Lee A, Sebastian K, Ulrich A, Pe\u00f1a S, Carpenter R, Sudhakar S, Uppal P, Fedeles BT, Sachs A, Dahbour L, Teeter W, Tanaka K, Galvagno SM, Herr DL, Scalea TM, Mazzeffi MA. Aspirin use is associated with decreased mechanical ventilation, intensive care unit admission, and in-hospital mortality in hospitalized patients with coronavirus disease 2019. Anesth Analg. 2021;132(4):930\u201341. A multicenter observational study on the effect of aspirin on mechanical ventilation, admission to ICU, and mortality in COVID-19 patients.","journal-title":"Anesth Analg"},{"issue":"6","key":"647_CR47","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1007\/s40256-020-00446-6","volume":"20","author":"G Patti","year":"2020","unstructured":"Patti G, Lio V, Cavallari I, Gragnano F, Riva L, Calabr\u00f2 P, Di Pasquale G, Pengo V, Rubboli A, Italian Study Group on Atherosclerosis, Thrombosis, Vascular Biology. Questions and Answers on Practical Thrombotic Issues in SARS-CoV-2 Infection: A Guidance Document from the Italian Working Group on Atherosclerosis, Thrombosis and Vascular Biology. Am J Cardiovasc Drugs. 2020;20(6):559\u201370.","journal-title":"Am J Cardiovasc Drugs."},{"key":"647_CR48","first-page":"9876819","volume":"2017","author":"SC Meyer","year":"2017","unstructured":"Meyer SC, Steinmann E, Lehmann T, Muesser P, Passweg JR, Skoda RC, Tsakiris DA. Anti-platelet factor 4\/heparin antibody formation occurs endogenously and at unexpected high frequency in polycythemia vera. Biomed Res Int. 2017;2017:9876819.","journal-title":"Biomed Res Int"},{"issue":"1","key":"647_CR49","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1007\/s11239-017-1566-1","volume":"45","author":"R Castelli","year":"2018","unstructured":"Castelli R, Gallipoli P, Schiavon R, Teatini T, Deliliers GL, Bergamaschini L. High prevalence of heparin induced thrombocytopenia with thrombosis among patients with essential thrombocytemia carrying V617F mutation. J Thromb Thrombolysis. 2018;45(1):106\u201313.","journal-title":"J Thromb Thrombolysis"}],"container-title":["Current Hematologic Malignancy Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11899-021-00647-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11899-021-00647-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11899-021-00647-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,27]],"date-time":"2021-10-27T16:43:47Z","timestamp":1635353027000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11899-021-00647-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,29]]},"references-count":49,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["647"],"URL":"https:\/\/doi.org\/10.1007\/s11899-021-00647-z","relation":{},"ISSN":["1558-8211","1558-822X"],"issn-type":[{"type":"print","value":"1558-8211"},{"type":"electronic","value":"1558-822X"}],"subject":[],"published":{"date-parts":[[2021,9,29]]},"assertion":[{"value":"3 May 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Tiziano Barbui and Valerio De Stefano declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}